{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:00:55Z","timestamp":1791896455145,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajo.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T08:29:57Z","timestamp":1692952197000},"page":"108-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Ocular Manifestations and Outcomes in Children With Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison With Adult Patients"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-8271","authenticated-orcid":false,"given":"Yueh-Ling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-5727","authenticated-orcid":false,"given":"Tsung-Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4774-013X","authenticated-orcid":false,"given":"Li-Yen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Ju","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hsi","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Kun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-9912","authenticated-orcid":false,"given":"Hsin-Yuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1117-7878","authenticated-orcid":false,"given":"Hung-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-5269","authenticated-orcid":false,"given":"Kuo-Hsuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyong","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Hui-Kang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2023.08.009_bib0001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: Building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.ajo.2023.08.009_bib0002","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/1346-8138.14528","article-title":"Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: a case-control study","volume":"45","author":"Syu","year":"2018","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.ajo.2023.08.009_bib0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"14","key":"10.1016\/j.ajo.2023.08.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.18-24019","article-title":"Severe dry eye with combined mechanisms is involved in the ocular sequelae of SJS\/TEN at the chronic stage","volume":"59","author":"Sotozono","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2023.08.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2087578","article-title":"Factors contributing to long-term severe visual impairment in stevens-johnson syndrome and toxic epidermal necrolysis","volume":"2017","author":"Jongkhajornpong","year":"2017","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.08.009_bib0006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2009.06.085","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children","volume":"62","author":"Koh","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ajo.2023.08.009_bib0007","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.2010-3322","article-title":"Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"128","author":"Finkelstein","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ajo.2023.08.009_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/BCR.0000000000000208","article-title":"A 15-year review of pediatric toxic epidermal necrolysis","volume":"36","author":"Quirke","year":"2015","journal-title":"J Burn Care Res"},{"issue":"9","key":"10.1016\/j.ajo.2023.08.009_bib0009","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/1346-8138.16476","article-title":"Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"49","author":"Chi","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.ajo.2023.08.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3061084","article-title":"Clinical features and treatment outcomes among children with stevens-johnson syndrome and toxic epidermal necrolysis: a 20-year study in a tertiary referral hospital","volume":"2018","author":"Chatproedprai","year":"2018","journal-title":"Dermatol Res Pract"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/pde.12158","article-title":"Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States","volume":"31","author":"Moreau","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.ajo.2023.08.009_bib0012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40264-017-0608-0","article-title":"Severe physical complications among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"41","author":"Olteanu","year":"2018","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.ajo.2023.08.009_bib0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pde.14118","article-title":"Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution","volume":"37","author":"Sibbald","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"13","key":"10.1016\/j.ajo.2023.08.009_bib0014","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience","volume":"25","author":"Forman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajo.2023.08.009_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2016.03.020","article-title":"Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"166","author":"Catt","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"6982","key":"10.1016\/j.ajo.2023.08.009_bib0016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2023.08.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3186328","article-title":"HLA association with drug-induced adverse reactions","volume":"2017","author":"Fan","year":"2017","journal-title":"J Immunol Res"},{"issue":"suppl 11","key":"10.1016\/j.ajo.2023.08.009_bib0018","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/ICO.0000000000000605","article-title":"Genetic predisposition to Stevens-Johnson syndrome with severe ocular surface complications","volume":"34","author":"Ueta","year":"2015","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.ajo.2023.08.009_bib0019","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2023.08.009_bib0020","article-title":"Human leucocyte antigen association of patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications in Han Chinese","author":"Ma","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","article-title":"Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"160","author":"Sotozono","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.08.009_bib0022","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome","volume":"114","author":"Sotozono","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.08.009_bib0023","article-title":"Clinical aspects of stevens-johnson syndrome\/toxic epidermal necrolysis with severe ocular complications in Taiwan","volume":"8","author":"Ma","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3-s","key":"10.1016\/j.ajo.2023.08.009_bib0024","first-page":"52","article-title":"Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"90","author":"Liotti","year":"2019","journal-title":"Acta Biomed"},{"issue":"1","key":"10.1016\/j.ajo.2023.08.009_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt.1071","article-title":"The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA label","volume":"105","author":"Wang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajo.2023.08.009_bib0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2018.01.028","article-title":"Chronic ocular sequelae of Stevens-Johnson syndrome in children: long-term impact of appropriate therapy on natural history of disease","volume":"189","author":"Basu","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.08.009_bib0027","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical snalysis of Stevens-Johnson syndrome caused by Mycoplasma pneumoniae infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0028","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1542\/peds.2015-0278","article-title":"Outbreak of Mycoplasma pneumoniae-associated Stevens-Johnson syndrome","volume":"136","author":"Olson","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ajo.2023.08.009_bib0029","first-page":"331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim","year":"2013","journal-title":"KJO"},{"issue":"10","key":"10.1016\/j.ajo.2023.08.009_bib0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-3083.2010.03935.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital","volume":"25","author":"Ferr\u00e1ndiz-Pulido","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2023.08.009_bib0032","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ajo.2020.07.006","article-title":"Lid-related keratopathy in Stevens-Johnson syndrome: natural course and impact of therapeutic interventions in children and adults","volume":"219","author":"Shanbhag","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.08.009_bib0033","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0034","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/ICO.0b013e3181ae2691","article-title":"Mucous membrane grafting for lid margin keratinization in Stevens\u2013Johnson syndrome: results","volume":"29","author":"Iyer","year":"2010","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2023.08.009_bib0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ophtha.2011.01.046","article-title":"Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases","volume":"118","author":"Gregory","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2023.08.009_bib0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2015.07.002","article-title":"A novel technique for amniotic membrane transplantation in patients with acute Stevens-Johnson syndrome","volume":"14","author":"Ma","year":"2016","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2023.08.009_bib0037","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ophtha.2015.10.027","article-title":"Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome: a randomized control trial","volume":"123","author":"Sharma","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2023.08.009_bib0038","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaapos.2017.04.002","article-title":"Amniotic membrane transplants in the pediatric population","volume":"21","author":"Ahmad","year":"2017","journal-title":"J AAPOS"},{"issue":"3","key":"10.1016\/j.ajo.2023.08.009_bib0039","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jtos.2019.03.001","article-title":"Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"17","author":"Shanbhag","year":"2019","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2023.08.009_bib0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ajo.2011.03.011","article-title":"Oral mucosal graft to correct lid margin pathologic features in cicatricial ocular surface diseases","volume":"152","author":"Fu","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.08.009_bib0041","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2332\/allergolint.10-RAI-0261","article-title":"Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"59","author":"Chung","year":"2010","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0042","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajo.2006.09.029","article-title":"Strong sssociation between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese","volume":"143","author":"Ueta","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2023.08.009_bib0043","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1038\/srep04862","article-title":"Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement","volume":"4","author":"Ueta","year":"2014","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajo.2023.08.009_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080737","article-title":"Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and phenytoin-induced cutaneous adverse drug reactions in the South Indian Tamil population","volume":"11","author":"John","year":"2021","journal-title":"J Pers Med"},{"issue":"15","key":"10.1016\/j.ajo.2023.08.009_bib0045","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ajo.2023.08.009_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106321","article-title":"Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children","volume":"162","author":"Manuyakorn","year":"2020","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.ajo.2023.08.009_bib0047","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.4979","article-title":"Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population","volume":"29","author":"Sukasem","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.ajo.2023.08.009_bib0048","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.ajo.2023.08.009_bib0049","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","article-title":"Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations","volume":"73","author":"Hsiao","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ajo.2023.08.009_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eplepsyres.2017.05.015","article-title":"Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: a meta-analysis","volume":"135","author":"Wang","year":"2017","journal-title":"Epilepsy Res"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423003367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423003367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T19:53:10Z","timestamp":1717185190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423003367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"alternative-id":["S0002939423003367"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.08.009","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Manifestations and Outcomes in Children With Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison With Adult Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}